IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 40 filers reported holding IKENA ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,986 | -34.0% | 2,999 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $19,673 | +90.1% | 2,999 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $10,347 | +129237.5% | 2,999 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $8 | -99.9% | 2,999 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $11,000 | -15.4% | 2,999 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $13,000 | -27.8% | 2,999 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $18,000 | -52.6% | 2,999 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $38,000 | – | 2,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $5,982,667 | 2.02% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $13,348,353 | 1.61% |
| CHI Advisors LLC | 1,637,372 | $4,355,409 | 1.16% |
| BVF INC/IL | 2,503,071 | $6,658,169 | 0.28% |
| Artal Group S.A. | 1,549,513 | $4,122 | 0.23% |
| Orbimed Advisors | 2,933,941 | $7,804,283 | 0.15% |
| DAFNA Capital Management LLC | 122,517 | $325,895 | 0.09% |
| Oasis Management Co Ltd. | 140,000 | $372,400 | 0.07% |
| Verition Fund Management LLC | 1,580,375 | $4,203,798 | 0.07% |
| CORNERCAP INVESTMENT COUNSEL INC | 29,465 | $78,377 | 0.01% |